Compare Vistra Corp (VST) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vistra Corp vs GeneDx Holdings Corp — how do they compare? Vistra Corp trades at $146.31 (market cap $48.64B), while GeneDx Holdings Corp trades at $82.25 (market cap $2.44B). The key difference: Vistra Corp is far larger — about 19.9× GeneDx Holdings Corp's market cap, and Vistra Corp pays a 0.63% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| VST | WGS | |
|---|---|---|
Market Cap | $48.64B | $2.44B |
Sector | Technology | Technology |
52-Week High | $217.92 | $167.51 |
52-Week Low | $134.71 | $34.51 |
Enterprise Value | $70.58B | $2.48B |
Dividend Yield | 0.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VST trades at $147.54, up 3.27% today, with strong analyst support (90.9% buy ratings) and a $239.75 consensus price target suggesting 62% upside. Recent Q2 2026 earnings showed mixed results with an EPS miss but 30% EBITDA growth to $1.77 billion, driven by data center demand. Technical indicators are bearish with support at $141, while fundamentals show robust profitability (11.55% net margin) offset by high valuation multiples (P/E 24.44).
The outlook remains positive given Vistra's positioning in the AI-powered data center boom, though risks include ERCOT pricing volatility and hedging losses. With institutional ownership stable and dividend payments consistent, the stock offers growth exposure to electricity demand trends, but investors should monitor execution on 2026 guidance and competitive pressures in the utility sector.
GeneDx Holdings Corp (WGS) trades at $82.36, up 5.75% in 24 hours, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS and record testing volumes, though net income margins remain negative. The stock faces class action litigation risks but benefits from institutional buying and new product launches.
Outlook is mixed: bullish technicals and 91% buy ratings suggest upside to the $90 high target, but negative profitability and legal overhangs pose risks. Investors should weigh growth potential against financial sustainability and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
